Predicted to enable cell adhesion molecule binding activity; protein tyrosine phosphatase activity; and signaling receptor binding activity. Involved in several processes, including cellular response to platelet-derived growth factor stimulus; regulation of postsynaptic density assembly; and synaptic membrane adhesion. Is active in glutamatergic synapse. Biomarker of restless legs syndrome. Human ortholog(s) of this gene implicated in coronary artery disease; diabetes mellitus; hypertension; and type 2 diabetes mellitus. Orthologous to human PTPRD (protein tyrosine phosphatase receptor type D).
RGD Description
Predicted to enable cell adhesion molecule binding activity; protein tyrosine phosphatase activity; and signaling receptor binding activity. Involved in several processes, including cellular response to platelet-derived growth factor stimulus; regulation of postsynaptic density assembly; and synaptic membrane adhesion. Is active in glutamatergic synapse. Biomarker of restless legs syndrome. Human ortholog(s) of this gene implicated in coronary artery disease; diabetes mellitus; hypertension; and type 2 diabetes mellitus. Orthologous to human PTPRD (protein tyrosine phosphatase receptor type D); INTERACTS WITH (+)-schisandrin B; 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol.